Researcher Database

Miyazawa Yoshiyuki
Urology
Assistant Professor
Last Updated :2024/03/27

Researcher Profile and Settings

Researcher

  • Name

    Miyazawa Yoshiyuki

Affiliation

  • Urology, Assistant Professor

Profile and Settings

  • Name

    Yoshiyuki, Miyazawa

Affiliation

  • Gunma University, Assistant Professor

Affiliation

  • Affiliation

    Graduate School of Medicine

Degree

  • Doctor of Philosophy in Medical Science

Research Experience

  • Gunma University

Research Activities

Published Papers

  • Effect of Androgen-Deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer, Yoshiyuki Miyazawa, Takahiro Syuto, Yoshitaka Sekine, Masashi Nomura, Hidekazu Koike, Hiroshi Matsui, Yasuhiro Shibata, Kazuto Ito and Kazuhiro Suzuki, 2018, IN VIVO
  • A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2017, BMC UROLOGY
  • Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2017, ANTICANCER RESEARCH
  • Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Kato, Haruo; Furuya, Yosuke; Koike, Hidekazu; Suzuki, Kazuhiro, 2017, PROSTATE
  • Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Shibata, Yasuhiro; Arai, Seiji; Miyazawa, Yoshiyuki; Shuto, Takahiro; Nomura, Masashi; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Ito, Kazuto; Suzuki, Kazuhiro, 2017, PROSTATE
  • YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin, Nitta, Takashi; Koike, Hidekazu; Miyao, Takeshi; Miyazawa, Yoshiyuki; Kato, Haruo; Furuya, Yosuke; Sekine, Yoshitaka; Suzuki, Kazuhiro, 2017, ANTICANCER RESEARCH
  • Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy, Shibata, Yasuhiro; Kurihara, Sota; Arai, Seiji; Kato, Haruo; Suzuki, Tomomi; Miyazawa, Yoshiyuki; Koike, Hidekazu; Ito, Kazuto; Nakamura, Tetsuya; Suzuki, Kazuhiro, 2017, JOURNAL OF INVESTIGATIVE SURGERY
  • Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer, Kato, Haruo; Furuya, Yosuke; Miyazawa, Yoshiyuki; Miyao, Takeshi; Syuto, Takahiro; Nomura, Masashi; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, Nov. 2016, ANTICANCER RESEARCH
  • Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins, Furuya Y, Sekine Y, Kato H, Miyazawa Y, Koike H, Suzuki K, 2016, Prostate International
  • Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist, Miyazawa Y, Kato H, Arai S, Furuya Y, Sekine Y, Nomura M, Koike H, Matsui H, Shibata Y, Ito K, Suzuki K, 2015, Basic and Clinical Andrology
  • Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor, Kato, Haruo; Sekine, Yoshitaka; Furuya, Yosuke; Miyazawa, Yoshiyuki; Koike, Hidekazu; Suzuki, Kazuhiro, 2015, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
  • An accelerometer-based method for estimating fluidity in the sit-to-walk task, Asakura, Tomoyuki; Hagiwara, Hikaru; Miyazawa, Yoshiyuki; Usuda, Shigeru, Nov. 2015, JOURNAL OF PHYSICAL THERAPY SCIENCE
  • Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug, Endo, Yukie;Oka, Aina;Uehara, Akihito;Toki, Sayaka;Motegi, Sei-ichiro;Ishikawa, Osamu;Miyazawa, Yoshiyuki;Suzuki, Kazuhiro, 2020, JOURNAL OF DERMATOLOGY, 47, 10, E359, E360

MISC

  • Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor, Haruo Kato,Yoshitaka Sekine,Yosuke Furuya,Yoshiyuki Miyazawa,Hidekazu Koike,Kazuhiro Suzuki, May 2015, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 461, 1, 115, 121
  • An accelerometer-based method for estimating fluidity in the sit-to-walk task, Tomoyuki Asakura,Hikaru Hagiwara,Yoshiyuki Miyazawa,Shigeru Usuda, Nov. 2015, JOURNAL OF PHYSICAL THERAPY SCIENCE, 27, 11, 3565, 3569
  • An accelerometer-based method for estimating fluidity in the sit-to-walk task, Tomoyuki Asakura,Hikaru Hagiwara,Yoshiyuki Miyazawa,Shigeru Usuda, Nov. 2015, JOURNAL OF PHYSICAL THERAPY SCIENCE, 27, 11, 3565, 3569
  • Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer, Haruo Kato,Yosuke Furuya,Yoshiyuki Miyazawa,Takeshi Miyao,Takahiro Syuto,Masashi Nomura,Yoshitaka Sekine,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Kazuhiro Suzuki, Nov. 2016, ANTICANCER RESEARCH, 36, 11, 6141, 6149
  • Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Yasuhiro Shibata,Seiji Arai,Yoshiyuki Miyazawa,Takahiro Shuto,Masashi Nomura,Yoshitaka Sekine,Hidekazu Koike,Hiroshi Matsui,Kazuto Ito,Kazuhiro Suzuki, May 2017, PROSTATE, 77, 6, 672, 680
  • Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy, Yasuhiro Shibata,Sota Kurihara,Seiji Arai,Haruo Kato,Tomomi Suzuki,Yoshiyuki Miyazawa,Hidekazu Koike,Kazuto Ito,Tetsuya Nakamura,Kazuhiro Suzuki, 2017, JOURNAL OF INVESTIGATIVE SURGERY, 30, 4, 247, 251
  • Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy, Yasuhiro Shibata,Sota Kurihara,Seiji Arai,Haruo Kato,Tomomi Suzuki,Yoshiyuki Miyazawa,Hidekazu Koike,Kazuto Ito,Tetsuya Nakamura,Kazuhiro Suzuki, 2017, JOURNAL OF INVESTIGATIVE SURGERY, 30, 4, 247, 251
  • A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Yoshiyuki Miyazawa,Yoshitaka Sekine,Takahiro Syuto,Masashi Nomura,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Kazuhiro Suzuki, Aug. 2017, BMC UROLOGY, 17, 70
  • Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells, Yoshiyuki Miyazawa,Yoshitaka Sekine,Haruo Kato,Yosuke Furuya,Hidekazu Koike,Kazuhiro Suzuki, Mar. 2017, PROSTATE, 77, 4, 337, 349
  • Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells, Yoshiyuki Miyazawa,Yoshitaka Sekine,Haruo Kato,Yosuke Furuya,Hidekazu Koike,Kazuhiro Suzuki, Mar. 2017, PROSTATE, 77, 4, 337, 349
  • Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Yoshiyuki Miyazawa,Yoshitaka Sekine,Takahiro Syuto,Masashi Nomura,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Kazuhiro Suzuki, Jul. 2017, ANTICANCER RESEARCH, 37, 7, 3667, 3671
  • Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Yoshiyuki Miyazawa,Yoshitaka Sekine,Takahiro Syuto,Masashi Nomura,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Kazuhiro Suzuki, Jul. 2017, ANTICANCER RESEARCH, 37, 7, 3667, 3671
  • YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin, Takashi Nitta,Hidekazu Koike,Takeshi Miyao,Yoshiyuki Miyazawa,Haruo Kato,Yosuke Furuya,Yoshitaka Sekine,Kazuhiro Suzuki, Jan. 2017, ANTICANCER RESEARCH, 37, 1, 75, 80
  • YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin, Takashi Nitta,Hidekazu Koike,Takeshi Miyao,Yoshiyuki Miyazawa,Haruo Kato,Yosuke Furuya,Yoshitaka Sekine,Kazuhiro Suzuki, Jan. 2017, ANTICANCER RESEARCH, 37, 1, 75, 80
  • Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Shibata\, Yasuhiro,Arai\, Seiji,Miyazawa\, Yoshiyuki,Shuto\, Takahiro,Nomura\, Masashi,Sekine\, Yoshitaka,Koike\, Hidekazu,Matsui\, Hiroshi,Ito\, Kazuto,Suzuki\, Kazuhiro, 2017, PROSTATE, 77, 6, 672, 680
  • Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer, Kato\, Haruo,Furuya\, Yosuke,Miyazawa\, Yoshiyuki,Miyao\, Takeshi,Syuto\, Takahiro,Nomura\, Masashi,Sekine\, Yoshitaka,Koike\, Hidekazu,Matsui\, Hiroshi,Shibata\, Yasuhiro,Ito\, Kazuto,Suzuki\, Kazuhiro, 2016, ANTICANCER RESEARCH, 36, 11, 6141, 6149
  • Effect of Androgen-Deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer, Yoshiyuki Miyazawa,Takahiro Syuto,Yoshitaka Sekine,Masashi Nomura,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Kazuhiro Suzuki, 2018, IN VIVO, 32, 2, 409, 412
  • Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins, Furuya Y,Sekine Y,Kato H,Miyazawa Y,Koike H,Suzuki K, 2016, Prostate International, 4, 2, 56, 60
  • Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist, Miyazawa Y,Kato H,Arai S,Furuya Y,Sekine Y,Nomura M,Koike H,Matsui H,Shibata Y,Ito K,Suzuki K, 2015, Basic and Clinical Andrology, 25, 7
  • Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor, Kato\, Haruo,Sekine\, Yoshitaka,Furuya\, Yosuke,Miyazawa\, Yoshiyuki,Koike\, Hidekazu,Suzuki\, Kazuhiro, 2015, 461, 1, 115, 121
  • Effect of Androgen-Deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer, Yoshiyuki Miyazawa,Takahiro Syuto,Yoshitaka Sekine,Masashi Nomura,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Kazuhiro Suzuki, 2018, 32, 2, 409, 412
  • A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Miyazawa\, Yoshiyuki,Sekine\, Yoshitaka,Syuto\, Takahiro,Nomura\, Masashi,Koike\, Hidekazu,Matsui\, Hiroshi,Shibata\, Yasuhiro,Ito\, Kazuto,Suzuki\, Kazuhiro, 2017, 17, 70
  • Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins, Furuya Y,Sekine Y,Kato H,Miyazawa Y,Koike H,Suzuki K, 2016, 4, 2, 56, 60
  • Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist, Miyazawa Y,Kato H,Arai S,Furuya Y,Sekine Y,Nomura M,Koike H,Matsui H,Shibata Y,Ito K,Suzuki K, 2015, 25, 7


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.